IVI and Bharat Biotech jointly launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The commencement of phase-II/III study of BBV87 in Costa Rica is a milestone and a first step towards developing a promising vaccine candidate against Chikungunya, an exhausting disease., The commencement of phase-II/III study of BBV87 in Costa Rica is a milestone and a first step towards developing a promising vaccine candidate against Chikungunya, an exhausting disease., , Read More